Growth Metrics

Cytosorbents (CTSO) Cash & Equivalents Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -9.44%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 19.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -36.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 36.60%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 40.99%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 34.11%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.52%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -0.70%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.25%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn -36.84%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -36.84%
Dec 31, 2025 -34.41%
Sep 30, 2025 -30.61%
Jun 30, 2025 -30.32%
Mar 31, 2025 -32.71%
Dec 31, 2024 -42.79%
Sep 30, 2024 -52.60%
Jun 30, 2024 -53.73%
Mar 31, 2024 -49.90%
Dec 31, 2023 -41.73%
Sep 30, 2023 -54.29%
Jun 30, 2023 -27.83%
Mar 31, 2023 -10.30%
Dec 31, 2022 21.88%
Sep 30, 2022 12.17%
Jun 30, 2022 22.67%
Mar 31, 2022 29.86%
Dec 31, 2021 32.59%
Sep 30, 2021 34.82%
Jun 30, 2021 37.42%
Mar 31, 2021 48.07%
Dec 31, 2020 60.35%
Sep 30, 2020 78.76%
Jun 30, 2020 28.88%
Mar 31, 2020 101.20%
Dec 31, 2019 32.61%
Sep 30, 2019 35.84%
Jun 30, 2019 23.52%
Mar 31, 2019 77.09%
Dec 31, 2018 61.43%
Sep 30, 2018 49.97%
Jun 30, 2018 46.64%
Mar 31, 2018 26.50%
Dec 31, 2017 68.74%
Sep 30, 2017 228.76%
Jun 30, 2017 49.81%
Mar 31, 2017 -20.37%
Dec 31, 2016 33.94%
Sep 30, 2016 39.47%
Jun 30, 2016 66.73%
Mar 31, 2016 37.35%
Dec 31, 2015 45.41%
Sep 30, 2015 53.02%
Jun 30, 2015 66.34%
Mar 31, 2015 79.45%
Dec 31, 2014 44.83%
Sep 30, 2014 -42.64%
Jun 30, 2014 12.61%
Mar 31, 2014 38.09%
Dec 31, 2013 27.40%
Sep 30, 2013 45.80%
Jun 30, 2013 46.45%